Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$56.67 - $69.36 $12,014 - $14,704
-212 Reduced 7.5%
2,615 $180,000
Q3 2023

Nov 14, 2023

BUY
$48.64 - $62.51 $5,253 - $6,751
108 Added 3.97%
2,827 $158,000
Q1 2023

May 15, 2023

SELL
$52.6 - $67.34 $21,092 - $27,003
-401 Reduced 12.85%
2,719 $148,000
Q4 2022

Jun 14, 2023

BUY
$59.56 - $76.6 $23,883 - $30,716
401 Added 14.75%
3,120 $195 Million
Q4 2022

Mar 30, 2023

BUY
$59.56 - $76.6 $10,423 - $13,404
175 Added 5.94%
3,120 $195,000
Q4 2022

Feb 15, 2023

BUY
$59.56 - $76.6 $10,423 - $13,404
175 Added 5.94%
3,120 $195,000
Q3 2022

Jun 14, 2023

BUY
$57.96 - $78.12 $13,098 - $17,655
226 Added 8.31%
2,945 $207 Million
Q3 2022

Mar 30, 2023

BUY
$57.96 - $78.12 $9,447 - $12,733
163 Added 5.86%
2,945 $207,000
Q3 2022

Nov 14, 2022

BUY
$57.96 - $78.12 $9,447 - $12,733
163 Added 5.86%
2,945 $207,000
Q2 2022

Jun 20, 2023

BUY
$39.5 - $64.42 $2,488 - $4,058
63 Added 2.32%
2,782 $157,000
Q2 2022

Mar 30, 2023

SELL
$39.5 - $64.42 $7,702 - $12,561
-195 Reduced 6.55%
2,782 $157,000
Q2 2022

Aug 11, 2022

SELL
$39.5 - $64.42 $7,702 - $12,561
-195 Reduced 6.55%
2,782 $158,000
Q1 2022

Jun 20, 2023

BUY
$43.74 - $62.76 $11,284 - $16,192
258 Added 9.49%
2,977 $186,000
Q1 2022

Mar 30, 2023

SELL
$43.74 - $62.76 $384,124 - $551,158
-8,782 Reduced 74.68%
2,977 $186,000
Q1 2022

May 12, 2022

SELL
$43.74 - $62.76 $384,124 - $551,158
-8,782 Reduced 74.68%
2,977 $186,000
Q4 2021

Jun 21, 2023

BUY
$50.01 - $73.35 $452,090 - $663,084
9,040 Added 332.48%
11,759 $658,000
Q3 2021

Jun 21, 2023

BUY
$59.21 - $78.66 $535,258 - $711,086
9,040 Added 332.48%
11,759 $765,000
Q3 2021

Mar 30, 2023

BUY
$59.21 - $78.66 $15,690 - $20,844
265 Added 2.31%
11,759 $765,000
Q3 2021

Nov 15, 2021

BUY
$59.21 - $78.66 $15,690 - $20,844
265 Added 2.31%
11,759 $765,000
Q2 2021

Jun 21, 2023

BUY
$51.39 - $66.9 $450,947 - $587,047
8,775 Added 322.73%
11,494 $728,000
Q2 2021

Mar 30, 2023

BUY
$51.39 - $66.9 $117,991 - $153,602
2,296 Added 24.96%
11,494 $728,000
Q2 2021

Aug 16, 2021

BUY
$51.39 - $66.9 $590,214 - $768,346
11,485 Added 127611.11%
11,494 $729,000
Q1 2021

Jun 26, 2023

BUY
$49.14 - $59.89 $318,378 - $388,027
6,479 Added 238.29%
9,198 $551 Million
Q1 2021

Mar 30, 2023

SELL
$49.14 - $59.89 $15,970 - $19,464
-325 Reduced 3.41%
9,198 $550,000
Q1 2021

May 14, 2021

SELL
$49.14 - $59.89 $467,517 - $569,793
-9,514 Reduced 99.91%
9 $551,000
Q4 2020

Jun 22, 2023

BUY
$42.19 - $51.5 $287,060 - $350,406
6,804 Added 250.24%
9,523 $475,000
Q3 2020

Jun 26, 2023

BUY
$35.33 - $51.04 $240,385 - $347,276
6,804 Added 250.24%
9,523 $486,000
Q2 2020

Jun 26, 2023

BUY
$22.91 - $39.83 $155,879 - $271,003
6,804 Added 250.24%
9,523 $334,000
Q2 2020

Mar 30, 2023

BUY
$22.91 - $39.83 $94,412 - $164,139
4,121 Added 76.29%
9,523 $334,000
Q2 2020

Aug 14, 2020

BUY
$22.91 - $39.83 $94,412 - $164,139
4,121 Added 76.29%
9,523 $334,000
Q1 2020

Jul 12, 2023

BUY
$16.44 - $37.73 $44,108 - $101,229
2,683 Added 98.68%
5,402 $137,000
Q4 2019

Jul 12, 2023

BUY
$19.57 - $28.96 $52,506 - $77,699
2,683 Added 98.68%
5,402 $149,000
Q3 2019

Jul 12, 2023

BUY
$26.92 - $42.41 $72,226 - $113,786
2,683 Added 98.68%
5,402 $145,000
Q3 2019

Mar 30, 2023

BUY
$26.92 - $42.41 $61,431 - $96,779
2,282 Added 73.14%
5,402 $145,000
Q3 2019

Nov 14, 2019

BUY
$26.92 - $42.41 $145,421 - $229,098
5,402 New
5,402 $145,000
Q2 2019

Jul 12, 2023

SELL
$18.54 - $40.97 $28,570 - $63,134
-1,541 Reduced 56.68%
1,178 $48.3 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.